6 Shoulder Replacement Rehab Myths the Research Contradicts

Anne Osborn, PT, MPT Anne Osborn, PT, MPT
10 minute read

Clinician reviewing total shoulder arthroplasty rehabilitation protocol with patient in outpatient clinic, shoulder replacement recovery

Listen to resource
Audio generated by DropInBlog's Blog Voice AI™ may have slight pronunciation nuances. Learn more

Table of Contents

Clinical Summary:

The Gap: These shoulder replacement rehabilitation myths are embedded in protocols across the country: only 23% of publicly available rehabilitation protocols for anatomic TSA closely follow ASSET consensus guidelines: which means most clinicians working in this area have absorbed at least some beliefs about shoulder replacement rehabilitation that don't match what the research actually shows.

The Evidence: Six specific myths, covering protocol timing, immobilization duration, subscapularis exercises, diabetes risk, home therapy, and reverse arthroplasty rehab, are directly contradicted by high-quality RCTs, systematic reviews, and consensus statements published from 2022 to 2025.

The Takeaway: Reading this article is not about feeling embarrassed by what you didn't know. It's about updating your clinical foundation with the best current evidence (which is exactly what shoulder replacement patients in 2025 deserve.

Shoulder replacement patients are arriving in outpatient clinics, home health settings, and athletic training rooms in greater numbers than ever. And most of the clinicians treating them are working from inherited protocols (frameworks passed down from supervisors, borrowed from online resources), or adapted from the pre-2020 literature without knowing what's changed.

That's not a failure of commitment. It's a failure of access to current evidence. A 2024 cross-sectional study found that only 23% of publicly available rehabilitation protocols for anatomic total shoulder arthroplasty closely adhered to ASSET consensus guidelines across all measured parameters. If the protocols are off, the clinical beliefs behind them likely are too.

Six Things Clinicians Still Believe About Shoulder Replacement Rehab That the 2022–2025 Research Contradicts

Here are the six shoulder replacement rehabilitation myths this research contradicts directly — along with what the evidence actually shows and what to do instead:

  1. Myth 1: Reverse arthroplasty is mainly for elderly patients with massive rotator cuff tears
  2. Myth 2: Starting rehabilitation earlier always produces better outcomes
  3. Myth 3: Adding subscapularis-specific exercises helps the repair heal faster
  4. Myth 4: Patients with diabetes need to be managed much more conservatively
  5. Myth 5: All TSA patients need formal physical therapy to achieve good outcomes
  6. Myth 6: Reverse TSA patients need 4–6 weeks of sling immobilization, just like anatomic TSA

Anatomic vs Reverse TSA: The clinical distinction between anatomic and reverse shoulder replacement

Myth 1: "Reverse arthroplasty is mainly for elderly patients with massive rotator cuff tears"

What the research shows: A 2024 population-based study using data from the National Joint Registry of England analyzed over 20,000 shoulder arthroplasties and found reverse arthroplasty associated with lower revision rates and comparable patient-reported outcomes in adults 75 and older with osteoarthritis, even when the rotator cuff was intact. A 2025 meta-analysis of 14 comparative studies confirmed that reverse arthroplasty demonstrates significantly lower complication and reoperation rates compared to anatomic arthroplasty in older patients with intact rotator cuffs. Indications now include complex proximal humerus fractures, failed prior arthroplasty, severe glenoid bone loss, and cases with limited preoperative forward elevation.

Clinical implication: You will see more reverse arthroplasty patients in your clinic than you did five years ago. And they will not all be 80-year-olds with rotator cuff tear arthropathy. The active 70-year-old, the patient with a complex fracture, and the revision case may all present with reverse prostheses. Each has different rehabilitation requirements that you need to understand going in.

What to do instead: Ask your patient which procedure they had and why, then pull the relevant protocol. Not one generic "shoulder replacement" protocol that blurs the two.

Reverse arthroplasty is no longer a last resort for the oldest, most complex patients. Expect to see it increasingly across age groups and diagnoses.

Myth 2: "Starting rehabilitation earlier always produces better outcomes"

What the research shows: A 2022 systematic review directly evaluated early (passive ROM from postoperative day 1) versus delayed (immobilization for 3–4 weeks before initiating motion) rehabilitation for anatomic TSA and found no significant differences in pain, function, health-related quality of life, or healing complications at 12-month follow-up. The 2023 APTA clinical practice guideline explicitly notes that delaying shoulder ROM initiation for up to 4 weeks does not negatively impact patient-reported outcomes and may be appropriate in patients with compromised tissue quality or complex surgical presentations.

Clinical implication: The assumption that earlier is always better can lead to inappropriate pressure on surgeons to release patients from restrictions, or to clinicians subtly encouraging progression before the tissue is ready. What matters is not just when you start, but whether you stay within the specific quantitative limits.

What to do instead: Follow the ASSET Phase 1 limits (120° elevation, 30° external rotation) regardless of when you start. This is the foundational shoulder replacement rehabilitation principle that separates evidence-based practice from habit-based practice. Early motion within these parameters prevents stiffness without increasing complication risk. Early motion outside them risks the subscapularis repair (the most common complication of anatomic TSA).

2022 Systematic Review Finding:

0

Significant outcome differences at 12 months between early and delayed rehabilitation after anatomic TSA. The limits matter more than the timing.

Subscapularis Failure After Shoulder Replacement: Subscapularis protection and detection guide

Myth 3: "Adding subscapularis-specific strengthening exercises helps the repair heal faster"

What the research shows: A 2023 prospective, double-blinded RCT compared standard ASSET-based rehabilitation to an enhanced protocol incorporating early subscapularis-specific internal rotation strengthening beginning at 6 weeks postoperatively. Result: no significant differences between groups in subscapularis strength, patient-reported outcomes, or complications at 3, 6, or 12-month follow-up. Both groups returned to baseline internal rotation strength by 3 months regardless of protocol.

Clinical implication: Adding extra subscapularis work is not harmful, but it is not evidence-based either. The standard phased protocol recommended by ASSET is sufficient for restoring subscapularis function in most patients. Directing clinical time toward exercises with no demonstrated benefit is an opportunity cost.

What to do instead: Follow the standard ASSET phased approach. Reserve enhanced subscapularis protocols for patients with documented risk factors for subscapularis insufficiency: compromised tissue quality, prior failed repairs, or specific intraoperative findings communicated by the surgeon.

Myth 4: "Patients with diabetes need to be managed much more conservatively after TSA"

What the research shows: A 2024 single-center retrospective study found no significant differences in complications, readmissions, or functional outcomes between patients with controlled diabetes (HbA1c <7.0%) and nondiabetic patients undergoing anatomic or reverse arthroplasty. The optimal HbA1c threshold for shoulder arthroplasty is most likely 7.5–8.0%, extrapolated from lower extremity arthroplasty evidence. Controlled diabetes, with appropriate medical management, does not require a fundamentally different rehabilitation timeline.

Clinical implication: Blanket conservatism for all diabetic patients, including delaying progression for patients with well-controlled glucose. That approach is not evidence-based and may unnecessarily slow functional recovery. The variable that matters is glycemic control, not the diagnosis of diabetes itself.

What to do instead: Assess glycemic control status and coordinate with the patient's medical team. Progress controlled diabetic patients on the standard timeline while performing enhanced wound surveillance at every session. Slow progression for patients with poorly controlled diabetes or wound healing concerns. Not for all diabetics by default.

Did You Know?

15–25% of patients undergoing shoulder arthroplasty have diabetes. A 2023 national readmissions study of over 113,000 shoulder arthroplasty patients found diabetes associated with significantly increased 90-day readmission and infection risk, but this risk is concentrated in patients with poor glycemic control, not all diabetic patients. The clinical target is controlling HbA1c, not restricting rehab.

 Home Therapy After Shoulder Replacement: The SHORT trial: home vs clinic after reverse TSA

Myth 5: "All TSA patients need formal physical therapy to achieve good outcomes"

What the research shows: The 2025 SHORT trial (a multicenter RCT of 222 shoulders, the Neer Award winner) found no statistically significant differences in any outcome measure at 1 or 2 years between patients randomized to surgeon-directed home therapy versus formal outpatient physical therapy after reverse TSA. Home therapy group one-year care cycle cost: $11,285. Formal PT group: $17,837. Difference: $6,552 per patient, p<0.01.

Clinical implication: Appropriately selected, well-educated reverse TSA patients can achieve equivalent outcomes at home. Formal PT is not required for every rTSA patient. And treating it as such misallocates resources away from patients who genuinely need intensive intervention.

What txo do instead: Identify patients who can succeed with home programs (generally uncomplicated rTSA with good compliance, no cognitive barriers, and no early complications) and those who need formal PT (complex cases, comorbidities, failure to progress, complications). Design exceptional home programs. The quality of that program is what makes the home model work.

The SHORT trial doesn't diminish the value of physical therapy. It identifies which patients need it most. And makes formal PT more valuable by reserving it for cases where it genuinely makes the difference.


Product Spotlight:

Total Shoulder Arthroplasty: Evidence-Based Update

Total Shoulder Arthroplasty: Evidence-Based Update

$37.97

This advanced continuing education course provides an up-to-date, evidence-based overview of rehabilitation and complication management after anatomic and reverse total shoulder arthroplasty (TSA). Using current research and clinical guidelines, the course reviews surgical indications, compares outcomes of anatomic vs. reverse… read more


Reverse Shoulder Replacement Rehabilitation: Immediate mobilization evidence for rTSA

Myth 6: "Reverse TSA patients need 4–6 weeks of sling immobilization, just like anatomic TSA"

What the research shows: A 2021 RCT of 357 rTSA patients randomized to no immobilization, 3-week sling, or 6-week sling found the no-immobilization group achieved non-inferior outcomes at one year. And had fewer postoperative complications. A 2023 multicenter prospective cohort study of 100 patients (mean age 74) using immediate active motion found only 5% of complications were potentially related to the rehabilitation strategy, with Constant scores improving from 16.6–22.6 preoperatively to 63.2–67.7 postoperatively across all groups.

Clinical implication: When the subscapularis is not repaired in rTSA (which is common in standard procedures) the primary rationale for immobilization is eliminated. Conservative sling use in these cases may increase fall risk, delay functional recovery, and prolong deconditioning in elderly patients without improving outcomes. The one precaution that remains: avoid combined adduction, internal rotation, and extension for 6–12 weeks. That position places the reverse prosthesis at greatest dislocation risk regardless of immobilization status.

What to do instead: Confirm with the surgical team whether the subscapularis was repaired. If not, follow an accelerated protocol with sling for comfort on day 1 only, and progress immediately to active-assisted and active range of motion. If the subscapularis was repaired, apply a hybrid protocol that incorporates Phase 1 protection similar to aTSA while acknowledging the inherent stability advantage of the reverse design.

Why Staying Current on Shoulder Replacement Rehabilitation Myths Isn't Optional

The gap between what the evidence shows and what most clinicians practice is not a knowledge failure. It's a dissemination failure. The ASSET consensus statement was published in 2020. The SHORT trial was published in 2025. The multicenter rTSA mobilization study was published in 2023. This is not ancient history. It's recent evidence that hasn't reached the protocols hanging on the walls of most outpatient clinics.

Staying current in this field means your patients get what the evidence supports, not what was standard when you trained. For a population where a 3–5% subscapularis failure rate, a 30-day readmission rate of 3.63%, and a $6,552 potential cost reduction per patient are all documented outcomes, that distinction is not academic. It's clinical. The clinician who treats their shoulder replacement patients with 2025 evidence is providing meaningfully better care than one working from 2015 assumptions. And their patients' outcomes will reflect it.

The Bottom Line

Evidence-based practice is not a personality type. It's a professional commitment, one that means updating your clinical foundation even when what you find contradicts what you were taught. The six myths in this article reflect beliefs that were either always underpowered or have been overturned by high-quality recent evidence. Updating them costs nothing. Working from the current evidence base costs nothing. The patients who receive care based on 2025 research rather than 2015 assumptions gain everything.

FAQs

What are the most common shoulder replacement rehabilitation myths?

The most evidence-contradicted beliefs in shoulder replacement rehabilitation involve immobilization duration for reverse TSA (immediate motion is safe in most cases), the necessity of formal PT (the SHORT trial found home programs equally effective), and the need for added subscapularis exercises (a 2023 RCT found no additional benefit over standard protocols).

Do ASSET guidelines really differ that much from common protocols?

Yes, significantly. A 2024 study found only 23% of publicly available protocols closely adhered to ASSET recommendations. Common deviations include variable sling durations (2–8 weeks instead of 4–6), inconsistent ROM limits, early active motion before 6 weeks, and premature strengthening, all of which carry clinical risk or reflect outdated evidence.

Should diabetic patients avoid shoulder replacement rehabilitation?

No. Controlled diabetes (HbA1c <7.0%) is not associated with significantly increased complication rates. The protocol modification for diabetic patients is not reduced activity. It is enhanced wound surveillance at every session and individualized progression based on healing status rather than fixed calendar timelines. Poor glycemic control, not the diabetes diagnosis itself, is the risk factor.

Is the SHORT trial finding applicable to all shoulder replacement patients?

The SHORT trial specifically studied reverse TSA patients. Its finding that home therapy achieves equivalent outcomes to formal PT does not apply universally. Patients with complications, multiple comorbidities, cognitive barriers, or failure to progress on home programs still need formal rehabilitation. The finding identifies which patients can safely succeed at home, not that formal PT has no value.

Professional Disclaimer

This content is for informational purposes for licensed clinicians and does not constitute medical advice or a substitute for your own clinical research and judgment. Content may include AI-synthesized information; all clinical data, protocols, and dosages must be verified against official primary sources prior to patient care. Any reference to CE rules or regulations is provided as a guide and must be independently verified against current governing body requirements prior to completing credits. This article may contain links to external websites or third-party AI platforms. Ridley Learning has no control over the nature, content, and availability of those sites and does not necessarily endorse the views expressed within them. Ridley Learning is not liable for any injury, loss, clinical outcomes, or licensure issues resulting from the use of or reliance on this information. Your use of this site constitutes acceptance of these terms.

Anne Perry Osborn, PT, MPT - Headshot

Meet the Author:
Anne Osborn, PT, MPT

Anne Perry Osborn is a distinguished physical therapist and entrepreneur with over two decades of experience bridging clinical practice and healthcare education. She holds a Master of Physical Therapy from Texas Tech University Health Sciences Center and currently serves as the Owner and Director of Quality and Accreditation at Ridley Learning. With a background that includes clinical roles in outpatient rehabilitation and home health, Anne brings practical, hands-on insight to her leadership in continuing education, ensuring that learning opportunities remain relevant and impactful for today's practitioners.

 Read More & View Courses 

Unlimited CE Membership

Get Unlimited Access CE

To get CE Credit for learning in this subject, check out the Unlimited Access membership - and get courses on this subject and more! With an Unlimited Access CE Membership, you get instant access to courses to meet your CE needs — whenever you need them.

 Learn More About Unlimited CE 

« Back to Blog